CHRS vs PEP · rev $26.6M vs P/E 22, rev $43.62B
Coherus BioSciences Inc (CHRS) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
CHRS currently screens at market cap $223.7M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the CHRS and PEP stock pages for the full models.
Not investment advice.